Article
Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
The Journal of pathology - 1 Nov 2011
Zlobec Inti, Bihl Michel, Foerster Anja, Rufle Alex, Lugli Alessandro
Abstract excerpt
CpG island methylator phenotype (CIMP) is being investigated for its role in the molecular and prognostic classification of colorectal cancer patients but is also emerging as a factor with the potential to influence clinical decision-making. We report a comprehensive analysis of clinico-pathological and molecular features (KRAS, BRAF and microsatellite instability, MSI) as well as of selected tumour- and...
Topics
- Adult
- Aged
- Aged, 80 and over
- Biomarkers, Tumor
- CDX2 Transcription Factor
- Colorectal Neoplasms
- CpG Islands
- DNA Methylation
- DNA, Neoplasm
- Female
- Homeodomain Proteins
